Sentence examples for efficacy now from inspiring English sources
At which point, the question becomes unavoidable: is efficacy now to be the benchmark for persecutors?
As can be seen, evaluation of different drug candidates for PrEP has taken a momentum and it is necessary to continually evaluate new candidates for this purpose since a PrEP with proven protective efficacy now may not retain its effectiveness in the future years given the propensity of HIV to develop drug resistance.
42– 44 With its efficacy now demonstrated, the investigator may be inclined to assess cabazitaxel in the same combinations currently being investigated with docetaxel.
An augmented self efficacy now fosters the belief that they as children have knowledge and skills that can make a difference.
Hence, the high efficacy now seen against chronic HBV infection in early adult life should result in high efficacy against HBV-related cirrhosis and liver cancer in future decades, even without booster doses for teenagers.
The importance of the clinical trial as the method of choice to determine efficacy is now well established, and the analytic techniques to conduct trials robustly are now so sophisticated that expertise is clustered in clinical trials units [ 38 ].
These thought-to-be antagonists with negative efficacy are now known as "inverse agonists".
The importance of the immune response against tumor antigens in virotherapy efficacy is now well recognized, however, its relative contribution versus the intrinsic oncolytic capacity of viruses has been difficult to evaluate.
Yet the preliminary results of NCAR's experiments, which are being done in Mexico and are due to run for another year, suggest that solid evidence of the technique's efficacy is now within the researchers' grasp.In this section No PERVersion Cloudbusting An ice idea Inside out ReprintsSeeds of faithThe term "rain-makers" is actually a bit misleading: rain-boosters would be better.
Further, reproducibility and validation of genetic association studies in the research area of CM management strongly need standardized and more accurate methods for unambiguous classification of therapy efficacy, till now based on patient self-reports [14, 15].
At the meeting, GlaxoSmithKline (GSK) of Rixensart, Belgium, which has the vaccine furthest in development, spelled out how it might scale up production in parallel with the safety and efficacy trials now under way so that the product could be ready for wider distribution by April if warranted.
